Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 270 participants.
Also called NCT06751459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 270 participants
- Sponsor
- HUINNO Co., Ltd
- Registry
-
NCT06751459
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06751459. Randomized; no masking; primary purpose supportive care. Start 2025-01-06 (anticipated); primary completion 2026-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy
- Acronym
- PREEMPT-AF
- Condition
- Atrial Fibrillation (AF)
- Intervention (Device)
- MEMO Patch 2 - 14-day Monitoring
- Intervention (Device)
- MEMO Patch 2 - 1-day Monitoring
- Intervention (Device)
- MEMO Link
- Lead sponsor
- HUINNO Co., Ltd
Record details
- Record id
cardio:ct-nct06751459- Content hash
2a5bc1e9f324d56fa6d002ce5c73e6f292933b1ff7031bf7a6169ed409c6dc6c